These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 17143742)

  • 1. Relation between plasma oxLDL antibodies and oxLDL in the circulation.
    Wang Y; Fang X; Wang S; Feng Y; Yin J
    Inflammation; 2007 Apr; 30(1-2):7-13. PubMed ID: 17143742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidized low-density lipoproteins, autoantibodies against oxidized low-density lipoproteins and carotid intima media thickness in a clinically healthy population.
    Chen HW; Kuo CL; Huang CS; Kuo SJ; Liu CS
    Cardiology; 2008; 110(4):252-9. PubMed ID: 18073481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies against oxidized LDL and carotid artery intima-media thickness in a healthy population.
    Fukumoto M; Shoji T; Emoto M; Kawagishi T; Okuno Y; Nishizawa Y
    Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):703-7. PubMed ID: 10712394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients.
    Ampuero J; Ranchal I; Gallego-Durán R; Pareja MJ; Del Campo JA; Pastor-Ramírez H; Rico MC; Picón R; Pastor L; García-Monzón C; Andrade R; Romero-Gómez M
    J Gastroenterol Hepatol; 2016 Sep; 31(9):1611-8. PubMed ID: 26946071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidized LDL and anti-oxLDL antibody levels in peripheral atherosclerotic disease.
    Andican G; Seven A; Uncu M; Cantaşdemir M; Numan F; Burçak G
    Scand J Clin Lab Invest; 2008; 68(6):473-8. PubMed ID: 18609113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidized low-density lipoproteins and their antibodies: relationships with the reverse cholesterol transport and carotid atherosclerosis in adults without cardiovascular diseases.
    Ferreira PF; Zago VH; D'Alexandri FL; Panzoldo NB; Gidlund MA; Nakamura RT; Schreiber R; Parra ES; Santiago FD; Nakandakare ER; Quintão EC; de Faria EC
    Clin Chim Acta; 2012 Oct; 413(19-20):1472-8. PubMed ID: 22659061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies against oxidized low-density lipoprotein (LDL) and carotid atherosclerosis in patients with rheumatoid arthritis.
    Wada Y; Kuroda T; Murasawa A; Tanabe N; Nakano M; Gejyo F
    Clin Exp Rheumatol; 2005; 23(4):482-6. PubMed ID: 16095116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-oxLDL antibodies are clinically insignificant for stroke patients.
    Masztalewicz M; Nowacki P; Kotlęga D; Bajer-Czajkowska A; Drechsler H
    Neurol Res; 2014 Jan; 36(1):86-91. PubMed ID: 24107551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma interleukin-5 levels are related to antibodies binding to oxidized low-density lipoprotein and to decreased subclinical atherosclerosis.
    Sämpi M; Ukkola O; Päivänsalo M; Kesäniemi YA; Binder CJ; Hörkkö S
    J Am Coll Cardiol; 2008 Oct; 52(17):1370-8. PubMed ID: 18940525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidized LDL to autoantibodies against oxLDL ratio - the new biomarker associated with carotid atherosclerosis and cardiovascular complications in dialyzed patients.
    Pawlak K; Mysliwiec M; Pawlak D
    Atherosclerosis; 2012 Sep; 224(1):252-7. PubMed ID: 22840691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inverse relationship between circulating oxidized low density lipoprotein (oxLDL) and anti-oxLDL antibody levels in healthy subjects.
    Shoji T; Nishizawa Y; Fukumoto M; Shimamura K; Kimura J; Kanda H; Emoto M; Kawagishi T; Morii H
    Atherosclerosis; 2000 Jan; 148(1):171-7. PubMed ID: 10580183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is oxidized low-density lipoprotein the connection between atherosclerosis, cardiovascular risk and nephrolithiasis?
    de Freitas ACP; Torres LC; Duarte MDCMB; da Matta MC; Casarini DE; Schor N
    Urolithiasis; 2019 Aug; 47(4):347-356. PubMed ID: 30302491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating oxidized low-density lipoprotein is associated with echolucent plaques in the femoral artery independently of hsCRP in 61-year-old men.
    Sigurdardottir V; Fagerberg B; Wikstrand J; Schmidt C; Hulthe J
    Atherosclerosis; 2007 Jan; 190(1):187-93. PubMed ID: 16494881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inverse relationship between total testosterone and anti-oxidized low density lipoprotein antibody levels in ageing males.
    Barud W; Palusiński R; Bełtowski J; Wójcicka G
    Atherosclerosis; 2002 Oct; 164(2):283-8. PubMed ID: 12204799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidized low-density lipoprotein autoantibodies, chronic infections, and carotid atherosclerosis in a population-based study.
    Mayr M; Kiechl S; Tsimikas S; Miller E; Sheldon J; Willeit J; Witztum JL; Xu Q
    J Am Coll Cardiol; 2006 Jun; 47(12):2436-43. PubMed ID: 16781371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Oxidized LDL and anti-oxidized LDL antibodies according uric acid levels in overweight women].
    Ruíz-Hernández N; Espinoza-Zavala M; González JC; Leal-Herrera U; Reigosa-Yaniz A
    Arch Cardiol Mex; 2011; 81(3):188-96. PubMed ID: 21975232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High circulating autoantibodies against human oxidized low-density lipoprotein are related to stable and lower titers to unstable clinical situation.
    Santos AO; Fonseca FA; Fischer SM; Monteiro CM; Brandão SA; Póvoa RM; Bombig MT; Carvalho AC; Monteiro AM; Ramos E; Gidlund M; Figueiredo Neto AM; Izar MC
    Clin Chim Acta; 2009 Aug; 406(1-2):113-8. PubMed ID: 19523463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating oxidized low-density lipoprotein is increased in hypertension.
    Frostegård J; Wu R; Lemne C; Thulin T; Witztum JL; de Faire U
    Clin Sci (Lond); 2003 Nov; 105(5):615-20. PubMed ID: 12837127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies against various forms of mildly oxidized low-density lipoprotein are not associated with carotid intima-media thickness in patients with primary hyperlipidemia.
    Tsouli SG; Kiortsis DN; Xydis V; Argyropoulou MI; Elisaf M; Tselepis AD
    Angiology; 2006; 57(5):615-22. PubMed ID: 17067985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relations between autoantibodies against oxidized low-density lipoprotein, inflammation, subclinical atherosclerosis, and cardiovascular disease in rheumatoid arthritis.
    Peters MJ; van Halm VP; Nurmohamed MT; Damoiseaux J; Tervaert JW; Twisk JW; Dijkmans BA; Voskuyl AE
    J Rheumatol; 2008 Aug; 35(8):1495-9. PubMed ID: 18597411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.